Science Daily: Pharmacology News
JANUARY 24, 2025
We're nearly one month into 2025, but if you're struggling to hold onto your New Year's resolution, stay strong, as new research shows that forming a healthy habit can take longer than you expect. Researchers found that new habits can begin forming within about two months (median of 59-66 days) but can take up to 335 days to establish.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- People can reverse their type 2 diabetes through a combination of calorie cutting and medication, a small clinical trial says.Overweight and obese adults caused their diabetes to go into remission by following a.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
JANUARY 24, 2025
Research reveals new evidence of early hominin activity in Europe, suggesting that hominins were present on the continent far earlier than previously thought.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- The last duck farm on New York's Long Island is facing an uncertain future after a bird flu outbreak forced the culling of nearly 100,000 ducks. The highly contagious H5N1 avian flu, otherwise known as bird flu, was.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
JANUARY 24, 2025
Researchers firmly point the finger at the South American Andes Mountains as the place where the Irish potato famine pathogen, Phtytophthora infestans, originated.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
JANUARY 24, 2025
Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent commissioner is confirmed.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- People using weed for medical purposes are as likely or more to become addicted to cannabis as recreational tokers, a new study says.Folks using medical marijuana were more likely to have cannabis use disorder than tho.
BioPharma Drive: Drug Pricing
JANUARY 24, 2025
An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts cautioned certain aspects of the study may have inflated its performance.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- Patients can improve their odds for a successful surgery by actively preparing for the procedure through diet and exercise, a tactic called prehabilitation, a new evidence review shows.Surgical patients who prehabbed had f.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
JANUARY 24, 2025
Merck and Eisai reported new data for a drug regimen of Keytruda and Lenvima. Elsewhere, AstraZeneca expanded in Canada and the FDA delayed a decision on Stealth’s Barth treatment.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- Hesitancy over the COVID-19 vaccine is leading some parents to skip important vaccinations for their children.Young children of parents who declined the COVID vaccine are about 25% less likely to get the standard.
Fierce BioTech
JANUARY 24, 2025
Patient Content Marketing 2.0: Leverage AI for efficient content creation, personalized delivery, and measurable outcomes dwunderlin Fri, 01/24/2025 - 16:27 Thu, 04/17/2025 - 11:00 Resource Type Webinar William Grambley Paul ONeill In an era defined by technological innovation, artificial intelligence (AI) is reshaping the landscape of pharmaceutical marketing.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems and diabetes.Add car wrecks to that list, a study published Jan. 21 in the journal OtolaryngologyHead and.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Science Daily: Pharmacology News
JANUARY 24, 2025
Researchers have used machine learning to design nano-architected materials that have the strength of carbon steel but the lightness of Styrofoam. The team describes how they made nanomaterials with properties that offer a conflicting combination of exceptional strength, light weight and customizability. The approach could benefit a wide range of industries, from automotive to aerospace.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- When one abortion pill faces lawsuits, another may be waiting in the wings, a new study suggests. The study, published Jan. 23 in the journal NEJM Evidence, has found a potential alternative to the abortion pill.
Science Daily: Pharmacology News
JANUARY 24, 2025
A scientific team looks at the progress and challenges in the research and development of brain implants. New achievements in the field of this technology are seen as a source of hope for many patients with neurological disorders and have been making headlines recently. As neural implants have an effect not only on a physical but also on a psychological level, researchers are calling for particular ethical and scientific care when conducting clinical trials.
Drug Channels
JANUARY 24, 2025
Todays guest post comes from Scott Genone, Chief Product Officer at CareMetx. Scott shares key takaways from CareMetxs recent survey of over 100 industry leaders. He outlines four trends that will define the future of patient services. To view the full survey results, download The 2025 Patient Services Report: Provider Engagement is Make or Break for Success.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Perficient: Drug Development
JANUARY 24, 2025
Introduction The advent of generative AI (GenAI) marks a pivotal moment in the evolution of healthcare, particularly in the context of acute care settings. As hospitals and health systems grapple with the challenges of increasing complexity, rising costs, and the ever-present need to improve patient outcomes, GenAI emerges as a transformative force, offering unparalleled opportunities to revolutionize healthcare delivery.
Conversations in Drug Development Trends
JANUARY 24, 2025
Metabolic dysfunction-associated steatohepatitis (MASH) presents a complex challenge in clinical trials due to its multifaceted nature and requirements for proper diagnosis. Addressing screen failure in MASH clinical trials is crucial, as it ensures the efficacy and safety profiles of potential treatments are accurately assessed from the onset. At Worldwide Clinical Trials, were committed to leveraging our MASH experience and patient-centric approach to navigate these challenges and drive better
Perficient: Drug Development
JANUARY 24, 2025
In Informatica Intelligent Cloud Services (IICS), In-Out and Input Parameters provide flexibility in managing dynamic values for your mappings. This allows you to avoid hard-coding values directly into the mapping and instead configure them externally through parameter files, ensuring ease of maintenance, especially in production environments. Below, well walk through the concepts and how to use these parameters effectively in your IICS mappings.
BioPharma Drive: Drug Pricing
JANUARY 24, 2025
The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats like competition from China.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- President Donald Trump's administration has placed a freeze on information being released from government health agencies.According to a memo obtained by the Associated Press, the "immediate pause" applies to information.
Drugs.com
JANUARY 24, 2025
FRIDAY, Jan. 24, 2025 -- A proposed ban on formaldehyde in chemical hair straightening products -- linked to cancer and other health risks -- has hit a roadblock after an executive order from President Donald Trump paused all new regulations. The.
Expert insights. Personalized for you.
327 
Let's personalize your content